Vykat XR™ (diazoxide choline) – New orphan drug approval
March 26, 2025 - Soleno Therapeutics announced the FDA approval of Vykat XR (diazoxide choline), for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome (PWS).
Download PDF
